Feeds

Aussie nano tech project gets AU$15m in global VC funding

Needle-free drug patches set to go commercial

  • alert
  • submit to reddit

Security for virtualized datacentres

A Queensland-based nanotech start-up has secured AU$15m in funding from a group of international biotechnology investors.

Venture capital firm One Venture is backing the creation of start-up vehicle Vaxxas, which will allow the University of Queensland’s Australian Institute for Bioengineering and Nanotechnology (AIBN) Professor Mark Kendall to work towards commercialising his patented Nanopatch technology,

The technology delivers vaccines to immune cells in the skin, instead of using a syringe method, which injects into the muscle. The Nanopatch, which is smaller than the size of a postage stamp and has the potential to be self-applied, was first conceived in 2003.

Co-investors in the new vehicle include US-based HealthCare Ventures, Brandon Capital, and the Medial Research Commercialisation Fund.

The University of Queensland’s main commercialisation company, UniQuest, has led the commercialisation of the Nanopatch technology to date, and will hand over the responsibility to Vaxxas following this investment.

Brandon Capital Partners Managing Director Dr Stephen Thompson says launching Vaxxas as a company is a critical next step for the Nanopatch technology.

“In Australia, we invest heavily in our excellent research and development capability but have a relatively poor record of taking those technologies to world markets,” he said.

In addition to improving the efficiency of delivery, the Nanopatch does not require refrigeration, making transport much cheaper and easier, particularly to developing nations around the world. ®

Top 5 reasons to deploy VMware with Tegile

More from The Register

next story
MEN: For pity's sake SLEEP with LOTS of WOMEN - and avoid Prostate Cancer
And, um, don't sleep with other men. If that's what worries you
Voyager 1 now EIGHTEEN LIGHT HOURS from home
Almost 20 BEEELION kilometres from Sol
HUGE SHARK as big as a WWII SUBMARINE died out, allowing whales to exist
Who'd win a fight: Megalodon or a German battleship?
Jim Beam me up, Scotty! WHISKY from SPAAACE returns to Earth
They're insured for $1m, before you thirsty folks make plans
ROGUE SAIL BOAT blocks SPACE STATION PODULE blastoff
Er, we think our ISS launch beats your fishing expedition
Comet Siding Spring revealed as flying molehill
Hiding from this space pimple isn't going to do humanity's reputation any good
BAE points electromagnetic projectile at US Army
Railguns for 'Future fighting vehicle'
OK Google, do I have CANCER?
Company talks up pill that would spot developing tumors
prev story

Whitepapers

Why and how to choose the right cloud vendor
The benefits of cloud-based storage in your processes. Eliminate onsite, disk-based backup and archiving in favor of cloud-based data protection.
A strategic approach to identity relationship management
ForgeRock commissioned Forrester to evaluate companies’ IAM practices and requirements when it comes to customer-facing scenarios versus employee-facing ones.
Reg Reader Research: SaaS based Email and Office Productivity Tools
Read this Reg reader report which provides advice and guidance for SMBs towards the use of SaaS based email and Office productivity tools.
New hybrid storage solutions
Tackling data challenges through emerging hybrid storage solutions that enable optimum database performance whilst managing costs and increasingly large data stores.
Website security in corporate America
Find out how you rank among other IT managers testing your website's vulnerabilities.